Hikal - Quaterly Results

09 Nov 2022 Evaluate
The revenue for the September 2022 quarter is pegged at Rs. 5587.50 millions, about 19.12% up against Rs. 4690.60 millions recorded during the year-ago period.Profit after Tax for the quarter ended September 2022 saw a decline of -43.61% from Rs. 440.50 millions to Rs. 248.40  millions.Operating Profit reported a sharp decline to 709.80 millions from 917.60 millions in the corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202209 202109 % Var 202209 202109 % Var 202203 202103 % Var
Sales 5587.50 4690.60 19.12 9375.40 9258.40 1.26 19427.20 17204.40 12.92
Other Income 12.50 8.70 43.68 45.20 40.50 11.60 48.90 49.80 -1.81
PBIDT 709.80 917.60 -22.65 969.20 1906.60 -49.17 3454.50 3278.70 5.36
Interest 108.00 79.60 35.68 220.90 159.50 38.50 312.10 362.00 -13.78
PBDT 601.80 838.00 -28.19 748.30 1747.10 -57.17 3142.40 2916.70 7.74
Depreciation 274.10 242.00 13.26 539.10 467.60 15.29 956.70 852.40 12.24
PBT 327.70 596.00 -45.02 209.20 1279.50 -83.65 2185.70 2064.30 5.88
TAX 79.30 155.50 -49.00 50.20 334.00 -84.97 580.60 732.80 -20.77
Deferred Tax 25.80 -4.70 -648.94 -3.30 -15.10 -78.15 -15.90 -62.70 -74.64
PAT 248.40 440.50 -43.61 159.00 945.50 -83.18 1605.10 1331.50 20.55
Equity 246.60 246.60 0.00 246.60 246.60 0.00 246.60 246.60 0.00
PBIDTM(%) 12.70 19.56 -35.06 10.34 20.59 -49.80 17.78 19.06 -6.69

Hikal Share Price

199.95 -0.55 (-0.27%)
22-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1634.40
Dr. Reddys Lab 1217.15
Cipla 1371.55
Zydus Lifesciences 884.85
Lupin 2165.05
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×